Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Continued use of an integrated meter with electronic logbook maintains improvements in glycemic control beyond a randomized, controlled trial.

Laffel LM, Hsu WC, McGill JB, Meneghini L, Volkening LK.

Diabetes Technol Ther. 2007 Jun;9(3):254-64.

PMID:
17561796
2.

Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.

Raccah D, Sulmont V, Reznik Y, Guerci B, Renard E, Hanaire H, Jeandidier N, Nicolino M.

Diabetes Care. 2009 Dec;32(12):2245-50. doi: 10.2337/dc09-0750. Epub 2009 Sep 18.

3.

Use of an insulin bolus advisor facilitates earlier and more frequent changes in insulin therapy parameters in suboptimally controlled patients with diabetes treated with multiple daily insulin injection therapy: results of the ABACUS trial.

Cavan DA, Ziegler R, Cranston I, Barnard K, Ryder J, Vogel C, Parkin CG, Koehler W, Vesper I, Petersen B, Schweitzer MA, Wagner RS.

Diabetes Technol Ther. 2014 May;16(5):310-6. doi: 10.1089/dia.2013.0280. Epub 2014 Apr 9.

PMID:
24716820
5.

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.

Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG; GWAA Study Group.

Ann Intern Med. 2005 Oct 18;143(8):559-69.

PMID:
16230722
6.

Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial.

Ziegler R, Cavan DA, Cranston I, Barnard K, Ryder J, Vogel C, Parkin CG, Koehler W, Vesper I, Petersen B, Schweitzer MA, Wagner RS.

Diabetes Care. 2013 Nov;36(11):3613-9. doi: 10.2337/dc13-0251. Epub 2013 Jul 30.

7.

The JDRF CCTN CGM TIME Trial: Timing of Initiation of continuous glucose Monitoring in Established pediatric type 1 diabetes: study protocol, recruitment and baseline characteristics.

Lawson ML, Bradley B, McAssey K, Clarson C, Kirsch SE, Mahmud FH, Curtis JR, Richardson C, Courtney J, Cooper T, Downie CJ, Rajamannar G, Barrowman N; CGM TIME Trial Study Group; JDRF Canadian Clinical Trial Network CCTN1101.

BMC Pediatr. 2014 Jul 18;14:183. doi: 10.1186/1471-2431-14-183.

8.

Overcoming Clinical Inertia: A Randomized Clinical Trial of a Telehealth Remote Monitoring Intervention Using Paired Glucose Testing in Adults With Type 2 Diabetes.

Greenwood DA, Blozis SA, Young HM, Nesbitt TS, Quinn CC.

J Med Internet Res. 2015 Jul 21;17(7):e178. doi: 10.2196/jmir.4112.

9.

Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study.

Bailey TS, Zisser HC, Garg SK.

Diabetes Technol Ther. 2007 Jun;9(3):203-10.

PMID:
17561790
10.

Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).

Murata GH, Shah JH, Hoffman RM, Wendel CS, Adam KD, Solvas PA, Bokhari SU, Duckworth WC; Diabetes Outcomes in Veterans Study (DOVES).

Diabetes Care. 2003 Jun;26(6):1759-63.

PMID:
12766106
11.

Alternate site glucose testing: a crossover design.

Bennion N, Christensen NK, McGarraugh G.

Diabetes Technol Ther. 2002;4(1):25-33; discussion 45-7.

PMID:
12017416
12.

Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.

Golden SH, Sapir T.

J Manag Care Pharm. 2012 Aug;18(6 Suppl):S1-17. Review.

PMID:
22984955
13.

Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software.

Garg SK, Bookout TR, McFann KK, Kelly WC, Beatson C, Ellis SL, Gutin RS, Gottlieb PA.

Diabetes Technol Ther. 2008 Oct;10(5):369-75. doi: 10.1089/dia.2007.0303.

14.

The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus.

Ehrhardt NM, Chellappa M, Walker MS, Fonda SJ, Vigersky RA.

J Diabetes Sci Technol. 2011 May 1;5(3):668-75.

15.

Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.

Malanda UL, Welschen LM, Riphagen II, Dekker JM, Nijpels G, Bot SD.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD005060. doi: 10.1002/14651858.CD005060.pub3. Review.

PMID:
22258959
16.

Advanced meter features improve postprandial and paired self-monitoring of blood glucose in individuals with diabetes: results of the Actions with the CONTOUR Blood Glucose Meter and Behaviors in Frequent Testers (ACT) study.

Bergenstal RM, Bode BW, Tamler R, Trence DL, Stenger P, Schachner HC, Fullam J, Pardo S, Kohut T, Fisher WA.

Diabetes Technol Ther. 2012 Oct;14(10):851-7.

PMID:
23013200
17.

Clinical factors associated with absolute and relative measures of glycemic variability determined by continuous glucose monitoring: an analysis of 480 subjects.

Jin SM, Kim TH, Bae JC, Hur KY, Lee MS, Lee MK, Kim JH.

Diabetes Res Clin Pract. 2014 May;104(2):266-72. doi: 10.1016/j.diabres.2014.02.003. Epub 2014 Feb 22.

PMID:
24630619
18.

A comparison of internet monitoring with continuous glucose monitoring in insulin-requiring type 2 diabetes mellitus.

Tildesley HD, Wright AM, Chan JH, Mazanderani AB, Ross SA, Tildesley HG, Lee AM, Tang TS, White AS.

Can J Diabetes. 2013 Oct;37(5):305-8. doi: 10.1016/j.jcjd.2013.05.006.

PMID:
24500556
19.

Web-based collaborative care for type 1 diabetes: a pilot randomized trial.

McCarrier KP, Ralston JD, Hirsch IB, Lewis G, Martin DP, Zimmerman FJ, Goldberg HI.

Diabetes Technol Ther. 2009 Apr;11(4):211-7. doi: 10.1089/dia.2008.0063.

20.

Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.

Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH.

Ann Intern Med. 2012 Sep 4;157(5):336-47. Review.

PMID:
22777524
Items per page

Supplemental Content

Write to the Help Desk